Warning
Aurobindo Pharma USA Inc Recalls Dicyclomine Hydrochloride Capsules
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0733-2026Drug / Pharmaceutical
Aurobindo Pharma USA Inc Recalls Dicyclomine Hydrochloride Capsules
Aurobindo Pharma USA Inc · Class II — Moderate Risk
Product Description
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Reason for Recall
shortfill; reports of empty capsules.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Aurobindo Pharma USA Inc initiated the recall on July 23, 2026 affecting 6,408 bottles distributed to market. shortfill; reports of empty capsules. The product was distributed in US Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Aurobindo Pharma USA Inc for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Other Injury Hazards.